GE Healthcare has introduced a number of new enhancements to its CardioLab electrophysiology (EP) recording system in order to improve its functionality.
The newly improved system has been optimised to minimise workflow bottlenecks and aid visualisation of electrical signals that are key to EP procedures, as well as supporting staff training and clinical research.
Among the specific improvements are enhanced signal display algorithms and streamlined multipath documentation and reporting workflows, making the CardioLab device quicker to operate.
According to the company, these enhancements are being rolled out in response to the growing need for EP studies among atrial fibrillation patients.
Jean-Michel Milles, general manager of interventional electrophysiology at GE Healthcare, said: "GE Healthcare sees its role as a partner helping to empower critical thinking of electrophysiologists. We are offering exceptional tools for clinical innovation, greater procedure efficacy and efficiency."
This week, the company also announced a new collaboration with Bionime that will see the latter organisation distributing GE-branded solutions for the diabetes market.See all the latest jobs in Medical Devices